Eleusis Benefit Corporation's Convertible Note Round

Eleusis Benefit Corporation raised a round of funding on February 07, 2014.

Eleusis Benefit Corporation seeks to develop and repurpose restricted small molecule drugs to safely address critical unmet needs.…

Articles about Eleusis Benefit Corporation's Convertible Note Round: